Axogen, Inc. (AXGN:NASDAQ) closed at $36.68 on October 22, 2026, up 0.55% on the day. The stock trades 30.7% below its 52-week high of $52.91 and 114.0% above its 52-week low of $17.14. Over the past year, it gained 103.2%. Axogen, Inc. is part of the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus).
In 252 trading sessions since October 22, 2025, AXGN closed higher on 136 days (54%). Its best day was October 29, 2025 (+23.06%) and its worst was September 10, 2026 (-11.47%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.
AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that...
Find more stocks like AXGN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.